In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates.
Kantarcioglu
A S
AS
Yucel
A
A
Vidotto
V
V
D000935:Antifungal Agents / Q000494:pharmacology*; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy; D001230:Aspergillus / Q000145:classification / Q000187:drug effects*; D002175:Candida / Q000145:classification / Q000187:drug effects*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy; D003453:Cryptococcosis / Q000175:diagnosis / Q000188:drug therapy; D003455:Cryptococcus neoformans / Q000187:drug effects* / Q000302:isolation & purification; D026141:Drug Resistance, Multiple, Fungal; D006801:Humans; D007558:Italy; D008826:Microbial Sensitivity Tests; D011090:Polyenes / Q000494:pharmacology*; D012680:Sensitivity and Specificity
D000935:Antifungal Agents; D011090:Polyenes; C115650:SPA S 843